Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-035006
Filing Date
2024-11-14
Accepted
2024-11-13 20:42:53
Documents
63
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ctdh20240930_10q.htm   iXBRL 10-Q 966871
2 EXHIBIT 31.1 ex_743569.htm EX-31.1 12469
3 EXHIBIT 31.2 ex_743570.htm EX-31.2 12464
4 EXHIBIT 32.1 ex_743571.htm EX-32.1 5007
5 EXHIBIT 32.2 ex_743572.htm EX-32.2 5008
  Complete submission text file 0001437749-24-035006.txt   5047809

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA ctdh-20240930.xsd EX-101.SCH 47821
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctdh-20240930_def.xml EX-101.DEF 349223
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctdh-20240930_lab.xml EX-101.LAB 275517
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctdh-20240930_pre.xml EX-101.PRE 366957
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ctdh-20240930_cal.xml EX-101.CAL 33143
66 EXTRACTED XBRL INSTANCE DOCUMENT ctdh20240930_10q_htm.xml XML 720796
Mailing Address PO BOX 1180 ALACHUA FL 32616-1180
Business Address 6714 NW 16TH STREET, SUITE B GAINESVILLE FL 32653 386-418-8060
Cyclo Therapeutics, Inc. (Filer) CIK: 0000922247 (see all company filings)

EIN.: 593029743 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39780 | Film No.: 241456511
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)